Integral Ad Science (NASDAQ:IAS) Price Target Cut to $18.00 by Analysts at Oppenheimer

Integral Ad Science (NASDAQ:IAS) had its target price decreased by Oppenheimer from $20.00 to $18.00 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Oppenheimer’s price target would suggest a potential upside of 73.58% from the company’s current price.

A number of other equities research analysts have also recently commented on the company. Benchmark reissued a “hold” rating on shares of Integral Ad Science in a research note on Monday, August 5th. Raymond James raised their price objective on Integral Ad Science from $13.00 to $15.00 and gave the company an “outperform” rating in a research note on Friday, August 2nd. Barclays raised their price objective on Integral Ad Science from $12.00 to $13.00 and gave the company an “equal weight” rating in a research note on Monday, August 5th. Finally, Morgan Stanley raised their price objective on Integral Ad Science from $12.00 to $13.00 and gave the company an “equal weight” rating in a research note on Tuesday, July 23rd. Three analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat.com, Integral Ad Science has an average rating of “Moderate Buy” and a consensus target price of $15.70.

Integral Ad Science Trading Down 3.7 %

NASDAQ IAS traded down $0.40 during trading hours on Wednesday, hitting $10.37. 170,925 shares of the company’s stock were exchanged, compared to its average volume of 1,385,157. The stock has a 50-day simple moving average of $11.11 and a 200 day simple moving average of $10.47. Integral Ad Science has a 1-year low of $7.98 and a 1-year high of $17.53. The firm has a market cap of $1.69 billion, a price-to-earnings ratio of 53.83, a PEG ratio of 1.46 and a beta of 1.52. The company has a current ratio of 3.71, a quick ratio of 3.76 and a debt-to-equity ratio of 0.07.

Integral Ad Science (NASDAQ:IAS) last released its earnings results on Tuesday, November 12th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.08 by $0.02. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. The business had revenue of $133.50 million during the quarter, compared to analysts’ expectations of $138.06 million. During the same quarter last year, the firm posted ($0.09) earnings per share. The firm’s revenue was up 11.0% on a year-over-year basis. On average, equities analysts forecast that Integral Ad Science will post 0.25 EPS for the current fiscal year.

Insider Activity at Integral Ad Science

In related news, CEO Lisa Utzschneider sold 10,481 shares of Integral Ad Science stock in a transaction on Monday, October 7th. The stock was sold at an average price of $10.11, for a total transaction of $105,962.91. Following the sale, the chief executive officer now directly owns 239,709 shares in the company, valued at approximately $2,423,457.99. This trade represents a 4.19 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Tania Secor sold 5,240 shares of Integral Ad Science stock in a transaction on Monday, October 7th. The stock was sold at an average price of $10.11, for a total value of $52,976.40. Following the sale, the chief financial officer now owns 248,223 shares in the company, valued at $2,509,534.53. This trade represents a 2.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 23,006 shares of company stock valued at $240,296 over the last 90 days. Insiders own 2.00% of the company’s stock.

Institutional Trading of Integral Ad Science

Hedge funds have recently bought and sold shares of the business. nVerses Capital LLC bought a new stake in Integral Ad Science during the third quarter worth $45,000. Ameritas Investment Partners Inc. raised its stake in shares of Integral Ad Science by 40.1% in the first quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company’s stock valued at $67,000 after buying an additional 1,924 shares during the period. Quantbot Technologies LP bought a new stake in shares of Integral Ad Science in the third quarter valued at $106,000. Stoneridge Investment Partners LLC bought a new stake in shares of Integral Ad Science in the third quarter valued at $125,000. Finally, XTX Topco Ltd bought a new stake in shares of Integral Ad Science in the second quarter valued at $113,000. 95.78% of the stock is currently owned by institutional investors.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.